Considerations when prescribing opioid agonist therapies for people living with HIV.
Saved in:
| Title: | Considerations when prescribing opioid agonist therapies for people living with HIV. |
|---|---|
| Authors: | Tarfa A; Yale AIDS Program, Yale University School of Medicine, New Haven, CT, USA., Lier AJ; Internal Medicine, Renaissance School of Medicine at Stony Brook University, Northport, NY, USA., Shenoi SV; Yale AIDS Program, Yale University School of Medicine, New Haven, CT, USA.; Veterans Administration Connecticut Healthcare System, West Haven, CT, USA., Springer SA; Yale AIDS Program, Yale University School of Medicine, New Haven, CT, USA.; Veterans Administration Connecticut Healthcare System, West Haven, CT, USA. |
| Source: | Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2024 Jul; Vol. 17 (7), pp. 549-564. Date of Electronic Publication: 2024 Jul 04. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278296 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-2441 (Electronic) Linking ISSN: 17512433 NLM ISO Abbreviation: Expert Rev Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
